There are many of us who have seen friends and loved ones die slowly and dehumanizingly as a result of Alzheimer’s disease. In the final stages of this and other dementia diseases, there comes a time when your loved one…
The elderly population of the U.S. frequently uses multiple prescription medications concurrently, known as polypharmacy. The more medications a person takes, the higher the risk of dangerous drug-drug interactions and the increased possibility of inappropriate prescribing, adverse drug reactions, hospitalization,…
A report produced by the Alzheimer’s Association (alz.org) provides statistics about Alzheimer’s disease. The findings give pause when contemplating the future of many Americans who will be living with crippling dementia. Health care and long-term care costs for individuals with…
The US Food and Drug Administration (FDA) recently approved a new drug under the trademark Aduhelm™ to treat Alzheimer’s disease. The drug, Aducanumab, is a therapeutic drug that clinically demonstrates a potential to delay further decline from Alzheimer’s disease and…
In the United States, we have a prevelant issue with polypharmacy, or the concurrent use of multiple medications. The more medications a person takes, the higher the risk of dangerous drug-drug interactions and increased possibility of inappropriate prescribing, adverse drug…
Within the next 20 years, the need for memory care housing options will become more necessary than ever. In 2016 alone, more than 2.5 million Baby Boomers turned 70 years old, the youngest boomers hitting age 52. With advancing age…
As part of his dedication to understanding, and being able to represent his clients with Alzheimer’s, or another Dementia, J. Bryan Nugen is a Certified Dementia Practitioner. What is Alzheimer’s Disease? Alzheimer’s disease is defined as an irreversible, progressive mental…
